Thus, the leptin-signaling pathway may have an important role to play in the development of PAH, but these data are novel in that they suggest leptin may not just promote pulmonary vascular disease in PAH (18) but may also affect the RV in PAH. This evidence concerns the gene LEP and pulmonary arterial hypertension.